On September 4, 2026 Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, reported that Sandesh Seth, Chairman and Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, being held September 14-16, 2026, in New York, NY. Company management will also be available for one-on-one meetings with investors.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details

Event: H.C. Wainwright 28th Annual Global Investment Conference
Presentation Date and Time: Monday, September 14, 2026, 3:00 – 3:30 p.m. ET
Location: New York, NY

Registered conference attendees may request a one-on-one meeting with management through their H.C. Wainwright representative.

(Press release, Actinium Pharmaceuticals, SEP 4, 2026, View Source [SID1234670594])